-
EP3609922
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3609922
| EP3609922 - ANTI-SIRP ALPHA ANTIBODIES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 04.03.2022 Database last updated on 18.11.2024 | |
| Former | Request for examination was made Status updated on 17.01.2020 | ||
| Former | The international publication has been made Status updated on 20.10.2018 | Most recent event Tooltip | 13.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states SAIROPA B.V. Stationsplein 45 Floor A4.004 3013 AK Rotterdam / NL | [2023/21] |
| Former [2022/10] | For all designated states SAIROPA B.V. Lichtenauerlaan 40 3062 ME Rotterdam / NL | ||
| Former [2020/08] | For all designated states Aduro Biotech Holdings, Europe B.V. Kloosterstraat 9 RX1101 5349 AB Oss / NL | Inventor(s) | 01 /
VAN EENENNAAM, Hans c/o Kloosterstraat 9 RX1101 5349 AB Oss / NL | 02 /
VAN ELSAS, Andrea c/o Kloosterstraat 9 RX1101 5349 AB Oss / NL | 03 /
VOETS, Erik c/o Kloosterstraat 9 RX1101 5349 AB Oss / NL | 04 /
VINK, Paul c/o Kloosterstraat 9 RX1101 5349 AB Oss / NL | 05 /
HULSIK, David Lutje c/o Kloosterstraat 9 RX1101 5349 AB Oss / NL | [2020/08] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2020/08] | Application number, filing date | 18784073.1 | 13.04.2018 | [2020/08] | WO2018NL50234 | Priority number, date | NL20172018708 | 13.04.2017 Original published format: NL 2018708 | NL20172019166 | 03.07.2017 Original published format: NL 2019166 | [2020/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2018190719 | Date: | 18.10.2018 | Language: | EN | [2018/42] | Type: | A2 Application without search report | No.: | EP3609922 | Date: | 19.02.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.10.2018 takes the place of the publication of the European patent application. | [2020/08] | Search report(s) | International search report - published on: | EP | 31.10.2019 | Classification | IPC: | C07K16/28, A61K39/00 | [2020/08] | CPC: |
C07K16/2803 (EP,IL,US);
C07K16/2896 (CN,KR);
A61K45/00 (CN);
A61P31/00 (EP,IL,KR);
A61P35/00 (EP,CN,IL,KR);
G01N33/57484 (EP,IL,KR,US);
G01N33/6854 (IL,US);
A61K2039/505 (CN,KR);
C07K2317/24 (EP,IL,KR,US);
C07K2317/33 (EP,IL,KR,US);
C07K2317/34 (EP,IL,KR,US);
C07K2317/52 (CN);
C07K2317/56 (CN);
C07K2317/565 (CN);
C07K2317/70 (EP,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/08] | Title | German: | ANTI-SIRP-ALPHA-ANTIKÖRPER | [2020/08] | English: | ANTI-SIRP ALPHA ANTIBODIES | [2020/08] | French: | ANTICORPS ANTI-SIRP ALPHA | [2020/08] | Entry into regional phase | 12.11.2019 | National basic fee paid | 12.11.2019 | Designation fee(s) paid | 12.11.2019 | Examination fee paid | Examination procedure | 12.11.2019 | Examination requested [2020/08] | 12.11.2019 | Date on which the examining division has become responsible | 09.06.2020 | Amendment by applicant (claims and/or description) | 04.03.2022 | Despatch of a communication from the examining division (Time limit: M04) | 13.07.2022 | Reply to a communication from the examining division | Fees paid | Renewal fee | 31.03.2020 | Renewal fee patent year 03 | 15.04.2021 | Renewal fee patent year 04 | 16.03.2022 | Renewal fee patent year 05 | 14.03.2023 | Renewal fee patent year 06 | 13.03.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO0066159 (FACULTEIT DER GENEESKUNDE VAN [NL], et al); | [IY]WO2013056352 (UNIV HEALTH NETWORK [CA], et al); | [Y]WO2015138600 (UNIV LELAND STANFORD JUNIOR [US]); | [IPY]WO2017178653 (OSE IMMUNOTHERAPEUTICS [FR]); | [T]WO2018190719 (ADURO BIOTECH HOLDINGS EUROPE B V [NL]); | [T]WO2018210793 (SYNTHON BIOPHARMACEUTICALS BV [NL]); | by applicant | US4399216 | US4439196 | US4447233 | US4447224 | US4487603 | EP0154316 | US4596556 | EP0216846 | EP0256055 | WO8801649 | US4740461 | US4790824 | US4816567 | EP0323997 | EP0338841 | US4912040 | US4941880 | US4946778 | US4959455 | EP0401384 | EP0404097 | US5064413 | WO9311161 | US5225539 | US5260203 | US5312335 | EP0604181 | WO9419357 | EP0618221 | WO9429351 | US5383851 | US5399163 | WO9508542 | WO9510514 | WO9510515 | WO9510516 | WO9511917 | WO9512612 | WO9512572 | US5420245 | WO9524612 | WO9525086 | EP0675112 | WO9532987 | WO9534535 | WO9600736 | EP0696593 | WO9605529 | WO9605168 | WO9605169 | WO9606138 | WO9606193 | US5510510 | WO9616443 | US5523430 | WO9617861 | US5530101 | US5532359 | US5532210 | WO9621701 | WO9621456 | WO9622278 | WO9624611 | WO9624612 | WO9630343 | WO9630017 | WO9630018 | WO9630362 | WO9630363 | WO9631111 | WO9631477 | WO9631478 | WO9631501 | WO9633159 | US5571792 | WO9634850 | WO9634851 | US5585089 | US5589485 | WO9700252 | WO9703047 | WO9703050 | WO9702920 | US5602098 | WO9704785 | US5624821 | WO9717070 | WO9718813 | WO9721701 | WO9723478 | US5648260 | WO9726246 | WO9730053 | US5661152 | US5677425 | WO9738665 | WO9744350 | US5693762 | WO9802436 | US5714350 | WO9828980 | WO9829119 | US5869046 | US5932448 | US6096002 | WO0044777 | WO0050032 | US6121022 | US6129914 | WO0061186 | US6165745 | US6194551 | US6277375 | US6284781 | US6288237 | US6329511 | US6331415 | US6350861 | WO02083064 | WO02083139 | WO02083140 | WO02083138 | WO03039460 | WO03050064 | WO03050122 | WO03049527 | WO03049679 | WO03049678 | US6620135 | WO03079973 | WO03084473 | WO03086310 | WO03086404 | WO03086279 | WO03086394 | WO03086403 | WO03099211 | WO03105855 | WO03106417 | WO2004037171 | WO2004039774 | WO2004041162 | US2004102360 | US2004116432 | WO2004058148 | WO2004058700 | WO2004096131 | WO2004096129 | WO2004096135 | WO2004096130 | WO2004112699 | US2005029941 | WO2005017190 | US2005044294 | US2005043361 | WO2005018638 | WO2005019206 | WO2005019205 | WO2005018547 | US2005176776 | US6946292 | WO2005100356 | WO2005100344 | WO2005120571 | US2006040887 | US7029872 | WO2006057702 | US7125689 | US7214775 | US7449308 | US2008286296 | US2012041057 | WO2013056352 | US2014205653 | WO2014179335 | WO2014179760 | US2015056224 | CA2939293 | WO2015185565 | WO2016096174 | WO2016145102 | WO2017011444 | WO2017027645 | WO2017027646 | WO2017123657 | WO2017123669 | WO2017175147 | WO2017175156 | WO2017178653 | US2018002369 | WO2018009648 | WO2018006652 | WO2018013887 | WO2018013908 | WO2018045204 | US2018092937 | US2018093964 | US20010310927 | US20020349925 | US20050652737 | US20050670469 | US20050734188 | NL20172018708 | NL20172019166 |